CURE RARE FOUNDATION (EIN 881224171) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

JESSICA LINDERMAN

Phone

3105455400

Tax Period

2022-01-01 to 2022-12-31

CURE RARE FOUNDATION, founded in 2022, is a small nonprofit in the Diseases & Disorders sector that reported $267K in total revenue in fiscal year 2022. The organization ran a surplus of $260K, a strong 97% operating margin.

Mission

Cure Rare Foundation, established in Spring 2022, is a nonprofit organization devoted to funding the research and development of treatments and cures for rare genetic diseases. In the United States, diseases are considered rare when a single condition affects fewer than 200,000 individuals. However, these diseases arent rare at all because over 7,000 rare diseases have been identified and there are over 25,000,000 people living with rare diseases in the US alone! Yet because each individual disease impacts a small population, research and development for treatments and cures are largely underfunded, resulting in less than 5% of rare disease having effective treatments.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $267,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $267,000

Expense Breakdown

Grants Paid $2,808

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $2,808

Other Expenses $4,627

TOTAL EXPENSES $7,435

Year-over-Year Comparison

	2022	2021	Change
Revenue	$267,000	N/A	N/A
Expenses	$7,435	N/A	N/A
Net Income	$259,565	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JESSICA LINDERMAN	President & CEO	4.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$267,000	$7,435	$262,374	$259,565

CURE RARE FOUNDATION